Article Sidebar

PDF
Date Published: 17/12/2022
Online Published: 17/01/2023
Abstract Views: 455
Views PDF: 223
DOI: https://doi.org/10.58490/ctump.2022i54.365
Issue
No. 54 (2022)
Section
Article
How to Cite
Tran, K. S., Vo , T. C., Ngo , H. T., Le , D. N., Bui, T. H. S., Phan, H. H., & Nguyen , T. P. A. (2023). CHARACTERISTICS OF PREMATURE VENTRICULAR COMPLEX AND RESULTS OF TREATMENT WITH BISOPROLOL IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY. Cantho Journal of Medicine and Pharmacy, 54, 105-111. https://doi.org/10.58490/ctump.2022i54.365

CHARACTERISTICS OF PREMATURE VENTRICULAR COMPLEX AND RESULTS OF TREATMENT WITH BISOPROLOL IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY

Kim Son Tran1, Tan Cuong Vo 2,, Hoang Toan Ngo 2, Dieu Ngan Le 2, Thi Hong Suong Bui2, Hong Hue Phan2, Thi Phuong Anh Nguyen 2
1 Can Tho University of Medicine and Pharmacy
2 Can Tho University of Medicine and Pharmacy Hospital

Main Article Content

Abstract

Background: Premature ventricular complex is a common arrhythmia, causing many symptoms, affecting the quality of life, even the onset of serious arrhythmias such as ventricular tachycardia, and ventricular fibrillation. The incidence of premature ventricular complexes is higher in patients with hypertension. Objectives: To study the characteristics and effects of bisoprolol in patients with hypertension and left ventricular hypertrophy. Materials and methods: A cross-sectional descriptive study was carried out of 76 patients with premature ventricular complexes, hypertension, and left ventricular hypertrophy at Can Tho University of Medicine and Pharmacy Hospital from 4/2019-6/2021. Results: In 76 patients (female accounts for 72.4%), the most common symptom is palpitations (59.2%); 25% of patients had complicated premature ventricular complexes (Lown III-V); Bisoprolol has effectively reduced count of premature ventricular complexes, heart rate, and symptoms after 4 weeks. Conclusions: Low-dose bisoprolol is effective in reducing the number of PVCs in hypertensive patients with LVH.

Article Details

Keywords

Premature ventricular complexes, hypertension, left ventricular hypertrophy

References

left ventricular function, Heart Rhythm, 7(7), pp.865-869.
2. Chatterjee S, Bavishi C et al. (2014), Meta-analysis of left ventricular hypertrophy and sustained arrhythmias, Journal of the American College of Cardiology, 114(7), pp.1049-1052.
3. Ghali J K et al. (1991), Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease, Journal of the American College of Cardiology, 17(6), pp.1277-1282.
4. Hamon D et al. (2019), Premature ventricular contraction diurnal profiles predict distinct clinical characteristics and beta-blocker responses, Journal of cardiovascular electrophysiology, 30(6), pp.836-843.
5. Jin Kyung Hwang (2015), Clinical Characteristics and Features of Frequent Idiopathic Ventricular Premature Complexes in the Korean Population, The Korean Society of Cardiology, pp.391-397.
6. Johnson K, Oparil S et al. (2019), Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study, Journal of the American Heart Association, 8(8), 011961.
7. Kim Y G, Choi Y Y et al. (2021), Premature ventricular contraction increases the risk of heart failure and ventricular tachyarrhythmia, Scientific reports, 11(1), 12698.
8. Kunisek J et al. (2008), Influence of the type and degree of left ventricular hypertrophy on the prevalence of ventricular arrhythmias in patients with hypertensive heart disease, Medizinische Klinik, 103(10), pp.705-711.
9. Liang B, Zou F H et al. (2020), Chinese Herbal Medicine Dingji Fumai Decoction for Ventricular Premature Contraction: A Real-World Trial, BioMed research international.
10. Marcus G M (2020), Evaluation and Management of Premature Ventricular Complexes, Circulation,141(17), pp.1404-1418.
11. Niwano S, Wakisaka Y et al. (2009), Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function, Heart, 95, pp.1230-1237.
12. Shinohara M et al. (2017), Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease, Journal of cardiology, 70(3), pp.212-219.
13. Simpson R J Jr, Cascio W E et al. (2002), Prevalence of premature ventricular contractions in a population of African American and white men and women: The Atherosclerosis Risk in Communities (ARIC) study, American heart journal, 143(3), pp.535-540.
14. Sultana R, Sultana N et al. (2010), Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension, Journal of Ayub Medical College, Abbottabad: JAMC, 22(4), pp.155-158.
15. Zhong L et al. (2014), Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: A single-center retrospective study, Heart Rhythm, 11(2), pp.187-193.